Douglas G Watson
CIK 1171147 · Board of Director · last filed 2016-11-16
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
OSUR price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
52 LIBERTY CORNER ROAD
FAR HILLS, NJ 07931
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| OSUR | Director | 188,032 | $3.56 | $669.4K | -$746.8K | 15 | 2016-11-16 |
| WRIGHT MEDICAL GROUP INC (WMGI.Z) Delisted | Director | 0 | — | — | $0 | 2 | 2015-10-05 |
| DCTH | Director | 0 | $19.96 | $0 | $75.3K | 9 | 2014-07-10 |
| BIOMIMETIC THERAPEUTICS, INC. (BMTI) Delisted | Director | 55,125 | — | — | $0 | 11 | 2012-06-12 |
| JAVELIN PHARMACEUTICALS, INC (JAV) Delisted | Director | 0 | — | — | $25.4K | 8 | 2010-07-02 |
| GNTA | Director | 4 | $0.98 | $4 | $7.0K | 1 | 2007-08-13 |
| GENTA INC DE/ (GNTAD) Delisted | Director | — | — | — | $0 | 1 | 2007-07-13 |
Recent Filings · Page 3 of 7
65 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2012-01-05 | — | Grant (A) | +25,000 | $0 | |
| 2011-11-17 | OSUR | Sell (S) | −40,000 | -$334.9K | EDGAR |
| 2011-11-10 | OSUR | Exer (M) | +40,000 | $274.8K | EDGAR |
| 2011-06-16 | BIOMIMETIC THERAPEUTICS, INC. (BMTI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2011-05-31 | DCTH | Grant (A) | +8,347 | $0 | EDGAR |
| 2011-02-03 | OSUR | Grant (A) | +25,000 | $0 | EDGAR |
| 2011-01-24 | — | Grant (A) | +3,507 | $0 | |
| 2011-01-12 | DCTH | Grant (A) | +3,022 | $0 | EDGAR |
| 2010-12-09 | — | Grant (A) | — | $0 | |
| 2010-09-13 | — | Mixed | −1,543 | -$82.7K |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.